Uzma Chaudhry1,2, Pyotr G Platonov1,2, Robert Jablonowski3, Jean-Philippe Couderc4, Henrik Engblom3, Xiajuang Xia4, Björn Wieslander5, Brett D Atwater6, David G Strauss7, Jesper Van der Pals1,2, Martin Ugander5, Marcus Carlsson3, Rasmus Borgquist1,2. 1. Arrhythmia Clinic, Skåne University Hospital, Lund, Sweden. 2. Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden. 3. Department of Clinical Physiology and Nuclear Medicine, Skåne University Hospital and Lund University, Lund, Sweden. 4. Heart Research Follow-Up Program, University of Rochester, Rochester, NY, USA. 5. Department of Clinical Physiology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden. 6. Duke Clinical Research Institute, Durham, NC, USA. 7. Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.
Abstract
BACKGROUND: Myocardial scar burden quantification is an emerging clinical parameter for risk stratification of sudden cardiac death and prediction of ventricular arrhythmias in patients with left ventricular dysfunction. We investigated the relationships among semiautomated Selvester score burden and late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR) assessed scar burden and clinical outcome in patients with underlying heart failure, left bundle branch block (LBBB) and implantable cardioverter-defibrillator (ICD) treatment. METHODS: Selvester QRS scoring was performed on all subjects with ischemic and nonischemic dilated cardiomyopathy at Skåne University Hospital Lund (2002-2013) who had undergone LGE-CMR and 12-lead ECG with strict LBBB pre-ICD implantation. RESULTS: Sixty patients were included; 57% nonischemic dilated cardiomyopathy and 43% ischemic cardiomyopathy with mean left ventricular ejection fraction of 27.6% ± 11.7. All patients had scar by Selvester scoring. Sixty-two percent had scar by LGE-CMR (n = 37). The Spearman correlation coefficient for LGE-CMR and Selvester score derived scar was r = .35 (p = .007). In scar negative LGE-CMR, there was evidence of scar by Selvester scoring in all patients (range 3%-33%, median 15%). Fourteen patients (23%) had an event during the follow-up period; 11 (18%) deaths and six adequate therapies (10%). There was a moderate trend indicating that presence of scar increased the risk of clinical endpoints in the LGE-CMR analysis (p = .045). CONCLUSION: There is a modest correlation between LGE-CMR and Selvester scoring verified myocardial scar. CMR based scar burden is correlated to clinical outcome, but Selvester scoring is not. The Selvester scoring algorithm needs to be further refined in order to be clinically relevant and reliable for detailed scar evaluation in patients with LBBB.
BACKGROUND: Myocardial scar burden quantification is an emerging clinical parameter for risk stratification of sudden cardiac death and prediction of ventricular arrhythmias in patients with left ventricular dysfunction. We investigated the relationships among semiautomated Selvester score burden and late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR) assessed scar burden and clinical outcome in patients with underlying heart failure, left bundle branch block (LBBB) and implantable cardioverter-defibrillator (ICD) treatment. METHODS: Selvester QRS scoring was performed on all subjects with ischemic and nonischemic dilated cardiomyopathy at Skåne University Hospital Lund (2002-2013) who had undergone LGE-CMR and 12-lead ECG with strict LBBB pre-ICD implantation. RESULTS: Sixty patients were included; 57% nonischemic dilated cardiomyopathy and 43% ischemic cardiomyopathy with mean left ventricular ejection fraction of 27.6% ± 11.7. All patients had scar by Selvester scoring. Sixty-two percent had scar by LGE-CMR (n = 37). The Spearman correlation coefficient for LGE-CMR and Selvester score derived scar was r = .35 (p = .007). In scar negative LGE-CMR, there was evidence of scar by Selvester scoring in all patients (range 3%-33%, median 15%). Fourteen patients (23%) had an event during the follow-up period; 11 (18%) deaths and six adequate therapies (10%). There was a moderate trend indicating that presence of scar increased the risk of clinical endpoints in the LGE-CMR analysis (p = .045). CONCLUSION: There is a modest correlation between LGE-CMR and Selvester scoring verified myocardial scar. CMR based scar burden is correlated to clinical outcome, but Selvester scoring is not. The Selvester scoring algorithm needs to be further refined in order to be clinically relevant and reliable for detailed scar evaluation in patients with LBBB.
Authors: Stephanie A M Knippenberg; Galen S Wagner; Joey F A Ubachs; Anton Gorgels; Erik Hedström; Håkan Arheden; Henrik Engblom Journal: Ann Noninvasive Electrocardiol Date: 2010-07 Impact factor: 1.468
Authors: Sofia Åkerlund; Björn Wieslander; Madeleine Turesson; Robin Nijveldt; Igor Klem; Jakob Almer; Henrik Engblom; Galen S Wagner; Brett D Atwater; Martin Ugander Journal: J Electrocardiol Date: 2015-07-21 Impact factor: 1.438
Authors: Raymond Y Kwong; Anna K Chan; Kenneth A Brown; Carmen W Chan; H Glenn Reynolds; Sui Tsang; Roger B Davis Journal: Circulation Date: 2006-06-05 Impact factor: 29.690
Authors: Xiaojuan Xia; Björn Wieslander; David G Strauss; Galen S Wagner; Wojciech Zareba; Arthur J Moss; Jean-Philippe Couderc Journal: Europace Date: 2015-03-23 Impact factor: 5.214
Authors: Esben A Carlsen; Lia E Bang; Kiril A Ahtarovski; Thomas Engstrøm; Lars Køber; Henning Kelbæk; Niels Vejlstrup; Erik Jørgensen; Steffen Helqvist; Kari Saunamäki; Peter Clemmensen; Lene Holmvang; Galen S Wagner; Jacob Lønborg Journal: J Electrocardiol Date: 2012-05-01 Impact factor: 1.438
Authors: Einar Heiberg; Jane Sjögren; Martin Ugander; Marcus Carlsson; Henrik Engblom; Håkan Arheden Journal: BMC Med Imaging Date: 2010-01-11 Impact factor: 1.930
Authors: Uzma Chaudhry; Pyotr G Platonov; Robert Jablonowski; Jean-Philippe Couderc; Henrik Engblom; Xiajuang Xia; Björn Wieslander; Brett D Atwater; David G Strauss; Jesper Van der Pals; Martin Ugander; Marcus Carlsson; Rasmus Borgquist Journal: Ann Noninvasive Electrocardiol Date: 2017-03-01 Impact factor: 1.468